Natsumi Mutoh, Masamichi Moriya, Chendong Xu, Kumiko Kato, Satoshi Arai, Noriyuki Iwabuchi, Miyuki Tanaka, Yin Jinghua, Ronko Itamura, Kaoru Sakatani, Shinichi Warisawa
Journal: Behavioural brain research 2024;460():114820
PMID: 38128887
We conducted a randomized controlled trial to investigate the potential of Bifidobacterium breve M-16 V to improve mood in humans. In this evaluation, we incorporated the use of near-infrared spectroscopy (NIRS), which has been used to evaluate mood states in studies with small sample sizes. Participants were given B. breve M-16 V (20 billion cells/day) for 6 weeks, and their mood state was assessed before and after ingestion. NIRS data were collected at rest and during a mental arithmetic task (under stress). Intake of B. breve M-16 V decreased the heart rate under stress and increased levels of the GABA-like substance pipecolic acid in stool samples. In addition, B. breve M-16 V improved mood and sleep scores in participants with high anxiety levels. These results suggest that B. breve M-16 V affects the metabolites of the gut microbiota and has the potential to modulate the autonomic nervous system and to improve mood and sleep.
Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.
Full Text Sources:
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.